Does bile reflux influence the progression of barrett's esophagus to adenocarcinoma?

Journal of Neurogastroenterology and Motility

Volumn 20, Issue 1, 2014, Pages 124-126

  Masaoka, Tatsuhiro ^a   Suzuki, Hidekazu ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MESSENGER RNA; MICRORNA 221; MICRORNA 222; TRANSCRIPTION FACTOR CDX2;

BARRETT ESOPHAGUS; BILE REFLUX; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; NOTE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM;

EID: 84891720452     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm.2014.20.1.124     Document Type: Note

References (10)

1. Matsuzaki J, Suzuki H, Asakura K, et al. Gallstones increase the prevalence of Barrett's esophagus. J Gastroenterol 2010;45:171-178.
2. Hayes S, Ahmed S, Clark P. Immunohistochemical assessment for Cdx2 expression in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. J Clin Pathol 2011;64:110-113.
3. Boulanger J, Vézina A, Mongrain S, et al. Cdk2-dependent phosphorylation of homeobox transcription factor CDX2 regulates its nuclear translocation and proteasome-mediated degradation in human intestinal epithelial cells. J Biol Chem 2005;280:18095-18107.
4. Matsuzaki J, Suzuki H, Tsugawa H, et al. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology 2013;145:1300-1311.
5. Guan B, Li H, Yang Z, Hoque A, Xu X. Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts. Cancer 2013;119:1321-1329.
6. Csendes A, Smok G, Burdiles P, Braghetto I, Castro C, Korn O. Effect of duodenal diversion on low-grade dysplasia in patients with Barrett's esophagus: analysis of 37 patients. J Gastrointest Surg 2002;6:645-652.
7. Zaika E, Bhardwaj V, Wei J, et al. Proinflammatory cytokines and bile acids upregulate DeltaNp73 protein, an inhibitor of p53 and p73 tumor suppressors. PLoS One 2013;8:e64306.
8. Phillips RW, Frierson HF Jr, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 2003;27:1442-1447.
9. Makita K, Kitazawa R, Semba S, et al. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus. World J Gastroenterol 2013;19:536-541.
10. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA 2013;310:627-636.